News

Olympia Pharmaceuticals | 503B Outsourcer | 503A Compounding Pharmacy

Market 50/100How we got 50/100Source tierUnclassified sourceTier ceiling50/100Independent sourcesnot recordedPublished score50/100Scored at the ceiling for a unclassified source source — it cannot go higher. The number is the source page’s own score, hard-capped at the tier ceiling; corroboration is recorded but cannot lift a score past that cap. Under 40 a claim goes to review instead of publication. Full methodology →
July 28, 2026↗ source

Olympia Pharmaceuticals is promoting its services as a 503B FDA-registered outsourcing facility and affiliated 503A compounding pharmacy. The company highlights its ability to ship nationwide and offers a diverse catalog of injectable products, including weight management blends, hormone therapies, and longevity supplements. Their marketing emphasizes regulatory compliance, quality testing, and convenient logistics for healthcare providers.

Related peptides

BPC-157GLP-1 receptor agonistsGLP-1C-peptideNOTALongevityGLP-1 receptor agonistGLP-1R
We summarize, we don't invent — every detail here traces to a real, linked source, and the badge reflects how trustworthy that source is. Read the original and decide for yourself.